Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020

This statistic shows the cumulative potential biosimilars market in EU-5 countries and the U.S. between 2016 and 2020. The addressable biosimilars market in the United States in this time range is estimated to be worth almost 250 billion euros.

Cumulative potential biosimilars market in EU-5 countries and the U.S. between 2016 and 2020

Market size in billion euros
--
--
--
--
--
--
Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

September 2016

Region

United States, EU

Survey time period

as of December 2015

Supplementary notes

Addressable market is calculated based on projected growth of originator market without biosimiliar entry. Growth rate is based on historical growth and analogue analysis.
Conversion rate: 1 USD = 0.916562 EUR (01/20/2016).

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Generics and biosimilars"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.